Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
104.19
+3.08 (3.05%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Encompass Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,611 | 5,935 | 5,373 | 4,801 | 4,349 | 4,015 | |
Revenue Growth (YoY) | 10.02% | 10.46% | 11.91% | 10.41% | 8.31% | 12.58% |
Cost of Revenue | 305 | - | - | - | - | - |
Gross Profit | 7,306 | 5,935 | 5,373 | 4,801 | 4,349 | 4,015 |
Selling, General & Admin | 3,414 | 3,352 | 3,110 | 2,802 | 2,548 | 2,297 |
Depreciation & Amortization Expenses | 336 | 327.9 | 299.6 | 273.9 | 243.6 | 219.6 |
Other Operating Expenses | 1,229 | 1,202 | 1,099 | 993.7 | 927.2 | 839.1 |
Total Operating Expenses | 4,978 | 4,882 | 4,509 | 4,069 | 3,718 | 3,356 |
Operating Income | 2,328 | 1,053 | 864.5 | 731.8 | 630.2 | 659.4 |
Interest Income | 3.8 | 4.3 | 3 | 3.2 | 2.9 | 3.4 |
Interest Expense | -123.4 | -123.2 | -138 | -143.5 | -177.1 | -165.3 |
Other Non-Operating Income (Expense) | 35 | 18.8 | 20.1 | 15.7 | -5.2 | 7.5 |
Total Non-Operating Income (Expense) | -84.6 | -100.1 | -114.9 | -124.6 | -179.4 | -154.4 |
Pretax Income | 1,204 | 953 | 749.6 | 607.2 | 450.8 | 505 |
Provision for Income Taxes | 207.7 | 192.9 | 150.2 | 132.2 | 100.1 | 101.9 |
Net Income | 996.1 | 760.1 | 599.4 | 475 | 350.7 | 403.1 |
Minority Interest in Earnings | 144.6 | 192.9 | 140.9 | 111 | 93.6 | 103.2 |
Earnings From Discontinued Operations | 15.4 | -1 | -2.8 | -12 | 15.2 | 114.1 |
Net Income to Common | 866.9 | 566.2 | 455.7 | 352 | 272.3 | 414 |
Net Income Growth | 24.54% | 24.25% | 29.46% | 29.27% | -34.23% | 45.01% |
Shares Outstanding (Basic) | 100 | 101 | 100 | 100 | 99 | 99 |
Shares Outstanding (Diluted) | 102 | 102 | 102 | 101 | 100 | 100 |
Shares Change (YoY) | -0.32% | - | 0.89% | 0.90% | 0.20% | 0.40% |
EPS (Basic) | 6.09 | 5.62 | 4.53 | 3.51 | 2.58 | 3.02 |
EPS (Diluted) | 6.00 | 5.54 | 4.46 | 3.47 | 2.56 | 2.99 |
EPS Growth | 23.71% | 24.21% | 28.53% | 35.55% | -14.38% | 52.55% |
Free Cash Flow | 464.4 | 439.2 | 360.3 | 267.7 | 121.7 | 170.1 |
Free Cash Flow Growth | 5.74% | 21.90% | 34.59% | 119.97% | -28.45% | -45.46% |
Free Cash Flow Per Share | 4.56 | 4.30 | 3.53 | 2.64 | 1.21 | 1.70 |
Dividends Per Share | 0.740 | 0.720 | 0.640 | 0.600 | 0.860 | 1.120 |
Dividend Growth | 2.78% | 12.50% | 6.67% | -30.23% | -23.21% | - |
Gross Margin | 95.99% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 30.58% | 17.74% | 16.09% | 15.24% | 14.49% | 16.42% |
Profit Margin | 13.09% | 12.81% | 11.16% | 9.89% | 8.06% | 10.04% |
FCF Margin | 6.10% | 7.40% | 6.71% | 5.58% | 2.80% | 4.24% |
EBITDA | 2,664 | 1,381 | 1,164 | 1,006 | 873.8 | 879 |
EBITDA Margin | 35.00% | 23.27% | 21.66% | 20.95% | 20.09% | 21.89% |
EBIT | 2,328 | 1,053 | 864.5 | 731.8 | 630.2 | 659.4 |
EBIT Margin | 30.58% | 17.74% | 16.09% | 15.24% | 14.49% | 16.42% |
Effective Tax Rate | 17.25% | 20.24% | 20.04% | 21.77% | 22.20% | 20.18% |